Table 3.
Transplant outcomes
| Parameters | Total (n = 91) |
|---|---|
| Variables recorded after transplantation | |
| Recipient eGFR (eGFR-r), mL/min/1.73 m2, median (IQR)a | |
| At dischargeb | 57 (46–72) |
| 6 months | 56 (44–67) |
| 12 months | 60 (47–70) |
| 24 months | 55 (45–71) |
| 36 months | 55 (44–67) |
| Histopathological findings in indication biopsies, n (%) | |
| TCMR | 18 (19.8) |
| ABMR | 10 (11) |
| De novo/recurrent glomerulonephritis | 4 (4.4) |
| BK virus nephropathy | 3 (3.3) |
| Death-censored graft survival, %c | |
| 1 year | 100 |
| 3 years | 98 |
| 5 years | 95 |
| Patient survival, % | |
| 1 year | 100 |
| 3 years | 98 |
| 5 years | 98 |
ABMR antibody-mediated rejection, eGFR estimated glomerular filtration rate, IQR interquartile range, TCMR T cell-mediated rejection
aPatients who lost their graft were assigned an eGFR of 0 mL/min/1.73 m2
beGFR was recorded at the day of hospital discharge after kidney transplantation
cCauses of graft loss: ABMR (n = 6), BK virus nephropathy (n = 1), unknown (n = 2)